---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-015404"
form_type: "8-K"
ticker: "OGEN"
cik: "0001174940"
company_name: "ORAGENICS INC"
filed_at: "2024-04-22T23:59:59+00:00"
generated_at: "2026-06-03T13:34:07.147904+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Oragenics receives NYSE American noncompliance notice; equity $3.2M below $4M/$6M thresholds

## Summary
- NYSE American notified Oragenics it fails continued listing standards due to stockholders' equity of $3.2M as of Dec 31, 2023.
- Company must submit a compliance plan by May 18, 2024 to address Sections 1003(a)(ii) and 1003(a)(iii) deficiencies.
- Company has until October 18, 2025 to regain compliance; stock trades as OGEN.BC during this period.
- If plan is not accepted or compliance not achieved, Oragenics faces potential delisting from NYSE American.

## SEC filing metadata
- accession: 0001493152-24-015404
- form_type: 8-K
- ticker: OGEN
- cik: 0001174940
- company_name: ORAGENICS INC
- filed_at: 2024-04-22T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1174940/000149315224015404/0001493152-24-015404-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1174940/000149315224015404/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-015404
- JSON: https://secwatch.observer/filing/0001493152-24-015404.json
- Plain text: https://secwatch.observer/filing/0001493152-24-015404.txt

## Key facts
- Listing & Compliance Notices
  ORAGENICS INC received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii), 1003(a)(iii)).
  - Exchange: nyse american
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 1003(a)(ii), 1003(a)(iii)
  source text: or more if the listed company has reported losses from continuing operations and/or net losses in its five most recent fiscal years. The Company reported stockholders equity of $3.2 million as of December 31, 2023, and losses from continuing operations and/or net losses in its five most recent fiscal years ended December 31, 2023. The Notice further provides that
  evidence_url: https://www.sec.gov/Archives/edgar/data/1174940/000149315224015404/0001493152-24-015404-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.